1.许宁宁,余梓涵,刁世童,等.益生菌在代谢综合征中的潜在作用及研究进展[J].重庆医学,2019,48(13):2297-2300,2304.2.WANG Y,APPIAH-KUBI K,LAN T,et a1.PKGⅡ inhibits PDGF-BB triggered biological activities by phosphorylating PDGFRp in gastric cancer cells[J].Cell Biol Int,2018,42(10):1358-1369.3.CASClOS,FERLAR,D’ANDREA A,et a1.Expression of angiogenic regulators,VEGF and leptin,is regulated by the EGF/P13K/STAT3 pathway in colorectal cancer cells [J].J Cell Physiol,2009,221(1):189-194.4.益生菌类保健食品申报与审评规定(试行)[J]. 中国食品卫生杂志, 2005(04):369-370.5.袁宵潇, 罗飞宏. 肠道菌群与肥胖,糖尿病关系的研究进展[J]. 医学综述, 2020, 026(002):346-350.6.ZIMMET P,MAGLIANO D,MATSUZAWA Y,et a1.The metabolic syndrome:a global public health problem and a new definition[J].J Atheroscler Thromb,2005,12 (6):295-300.7.JOO N S,KIM B T,PARK S B,et a1.Different waist circumferences,different metabolic risks in Koreans[J].J Am Board Fam Med,2007,20(3):258.8.付俊玲,肖新华.代谢综合征的定义和流行病学[J].临床内科杂志,2018(1):5-9.9.LIU Ruixin, HONG Jie, XU Xiaoqiang, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention[J]. Nature Medicine, 2017, 23(7): 859-868.10.CHEN Yungtsung, YANG Ningsun, LIN Yuchun, et al. A combination of Lactobacillus mali APS1 and dieting improved the efficacy of obesity treatment via manipulating gut microbiome in mice[J]. Scientific Reports, 2018, 8(1): 1-14.11.方圆圆. 益生菌对儿童肥胖症治疗的研究进展[J]. 国际儿科学杂志, 2018, 45(2):125-128.12.Jialal I, Huet BA, Kaur H, et al. Increased Toll-like receptor activity in patients with metabolic syndrome[ J]. Diabetes Care, 2012,35(4):900-904.13.廖文艳,王豪,周杰,等.益生菌在肥胖及其代谢综合症中的潜在作用[J]. 东北农业大学学报, 2011(08):159-164.14.张霆.益生菌在儿童生长发育中的作用[J].中国儿童保健杂志,2018,26(8):816-818.15.刘卓群,马亚楠,闻德亮等.益生菌,益生元对肥胖的治疗及其机制的研究进展[J]. 中国微生态学杂志,2018,30(9):1096-1101.